| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Commercial Officer
2 companies
Ajer Jeffrey Robert is an EVP, Chief Commercial Officer at BMRN, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 56 sales. Those positions are worth an estimated $5.5M at current prices.
Our model assigns Ajer Jeffrey Robert a middling insider score of 58/100, based on 20 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of +0.3%.
Ajer Jeffrey Robert's largest disclosed position is in BMRN as EVP, Chief Commercial Officer, worth about $5.5M. The recent filings there lean toward selling, a net 187,144 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell10b5-1 | 5,000 | $82.91 | $414,550.00 | -7.0% | +0.6% | -26.0% | |
| Mar 5, 2024 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell10b5-1 | 4,000 | $87.07 | $348,280.00 | -4.1% | -11.2% | -17.2% | |
| Sep 18, 2023 | NKTR Nektar Therapeutics | Director | Sell | 4,359 | $0.69 | $3,007.71 | -11.3% | -28.6% | +89.8% | |
| Aug 16, 2023 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell10b5-1 | 5,000 | $90.00 | $450,000.00 | -7.6% | -5.7% | -0.9% | |
| Jan 25, 2023 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sale+OE | 49,000 | $115.70 | $5,669,133.50 | -54.4% | -17.6% | -21.4% | |
| Nov 2, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 3,000 | $86.12 | $258,360.00 | -6.8% | +37.0% | -5.3% | |
| Sep 23, 2022 | NKTR Nektar Therapeutics | Director | Sell | 4,198 | $3.16 | $13,265.68 | -9.8% | -26.8% | -80.4% | |
| Aug 11, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 3,000 | $95.62 | $286,860.00 | -6.4% | -14.9% | -6.0% | |
| May 26, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 1,308 | $78.94 | $103,253.52 | -2.4% | +17.8% | +12.2% | |
| Apr 13, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 1,180 | $82.47 | $97,314.60 | -2.1% | +4.6% | +17.1% |